BR112013010043A2 - formulação farmacêutica na forma de filme e uso de uma combinação de excipientes farmacêuticas aceitáveis. - Google Patents
formulação farmacêutica na forma de filme e uso de uma combinação de excipientes farmacêuticas aceitáveis.Info
- Publication number
- BR112013010043A2 BR112013010043A2 BR112013010043A BR112013010043A BR112013010043A2 BR 112013010043 A2 BR112013010043 A2 BR 112013010043A2 BR 112013010043 A BR112013010043 A BR 112013010043A BR 112013010043 A BR112013010043 A BR 112013010043A BR 112013010043 A2 BR112013010043 A2 BR 112013010043A2
- Authority
- BR
- Brazil
- Prior art keywords
- combination
- film form
- pharmaceutical formulation
- acceptable
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010049708A DE102010049708A1 (de) | 2010-10-28 | 2010-10-28 | Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe |
| PCT/EP2011/068813 WO2012055944A1 (de) | 2010-10-28 | 2011-10-27 | Orale pharmazeutische filmformulierung für bitter schmeckende arzneistoffe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013010043A2 true BR112013010043A2 (pt) | 2019-09-24 |
Family
ID=44999743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013010043A BR112013010043A2 (pt) | 2010-10-28 | 2011-10-27 | formulação farmacêutica na forma de filme e uso de uma combinação de excipientes farmacêuticas aceitáveis. |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20130217697A1 (pt) |
| EP (1) | EP2632429A1 (pt) |
| JP (1) | JP6049624B2 (pt) |
| BR (1) | BR112013010043A2 (pt) |
| DE (1) | DE102010049708A1 (pt) |
| WO (1) | WO2012055944A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010049708A1 (de) | 2010-10-28 | 2012-05-03 | Hexal Ag | Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe |
| CA2864322C (en) * | 2012-02-28 | 2016-08-09 | Seoul Pharma. Co., Ltd. | High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
| EP2730178B1 (de) * | 2012-11-12 | 2020-08-26 | Symrise AG | Zubereitungen zur oralen Aufnahme |
| CN104739809B (zh) * | 2013-12-30 | 2018-06-15 | 广州朗圣药业有限公司 | 能提供高载药量的水不溶性药物的膜剂及其制备方法 |
| NO2723977T3 (pt) * | 2014-03-19 | 2018-03-10 | ||
| WO2018122867A1 (en) * | 2016-12-27 | 2018-07-05 | Zim Laboratories Limited | Thin film formulations of 4-diphenylmethyl-1-piperazine derivatives and their salts |
| EP3813789A1 (en) | 2018-06-28 | 2021-05-05 | Arx, LLC | Dispensing method for producing dissolvable unit dose film constructs |
| US11179331B1 (en) | 2020-04-21 | 2021-11-23 | Cure Pharmaceutcai Holding Corp | Oral soluble film containing sildenafil citrate |
| JPWO2021235424A1 (pt) * | 2020-05-18 | 2021-11-25 | ||
| WO2022106923A1 (en) | 2020-11-18 | 2022-05-27 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising an antihistamine compound |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
| US5846557A (en) * | 1996-03-20 | 1998-12-08 | Cumberland Packing Corporation | Chewing gum containing cough suppressing agent |
| US20030211136A1 (en) * | 1998-09-25 | 2003-11-13 | Neema Kulkarni | Fast dissolving orally consumable films containing a sweetener |
| DE10207394B4 (de) | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
| WO2004019885A2 (en) | 2002-08-29 | 2004-03-11 | Linguagen Corp. | Fast dissolving film delivery of nucleotides that inhibit the unpleasant taste of bitter tasting medications |
| WO2004043165A1 (en) | 2002-11-14 | 2004-05-27 | Givaudan Sa | Edible film containing food acid |
| US20060024335A1 (en) | 2004-07-29 | 2006-02-02 | Roger Stier E | Oral compositions which mask the bitter taste of a bitter-tasting agent |
| US20060024425A1 (en) | 2004-07-30 | 2006-02-02 | Wm. Wrigley Jr. Company | Edible film compositions |
| WO2006072921A2 (en) * | 2005-01-07 | 2006-07-13 | Ranbaxy Laboratories Limited | Sweetener composition of stevia extract and maltol and processes of preparation thereof |
| DE102005033942A1 (de) | 2005-07-20 | 2007-02-22 | Hexal Ag | Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für Antiemetikum oder Antimigränemittel |
| DE102005033943A1 (de) | 2005-07-20 | 2007-02-22 | Hexal Ag | Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum |
| US20070178123A1 (en) * | 2006-01-27 | 2007-08-02 | Deborah Levenson | Flavor-enhancing compositions, method of manufacture, and methods of use |
| PL2248519T3 (pl) | 2006-10-02 | 2018-04-30 | Apr Applied Pharma Research S.A. | Niemukoadhezyjne postaci dawkowania w postaci filmu |
| EP2008530B1 (de) | 2007-06-19 | 2011-01-19 | Symrise AG | Aromakomposition zum Verringern oder Unterdrücken von unerwünschtem bitteren und adstringierenden Eindruck |
| US20090047330A1 (en) | 2007-08-17 | 2009-02-19 | Ramesh Bangalore | Oral fast dissolving films for erectile dysfunction bioactive agents |
| KR100905027B1 (ko) * | 2007-10-03 | 2009-06-30 | (주)씨엘팜 | 식용 필름 |
| MX2010004265A (es) * | 2007-10-19 | 2010-07-28 | Innozen Inc | Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. |
| CN101574330A (zh) * | 2009-06-12 | 2009-11-11 | 上海现代药物制剂工程研究中心有限公司 | 苯甲酸利扎曲普坦膜剂 |
| DE102010049708A1 (de) | 2010-10-28 | 2012-05-03 | Hexal Ag | Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe |
-
2010
- 2010-10-28 DE DE102010049708A patent/DE102010049708A1/de not_active Withdrawn
-
2011
- 2011-10-27 EP EP11784961.2A patent/EP2632429A1/de not_active Withdrawn
- 2011-10-27 WO PCT/EP2011/068813 patent/WO2012055944A1/de active Application Filing
- 2011-10-27 JP JP2013535427A patent/JP6049624B2/ja not_active Expired - Fee Related
- 2011-10-27 BR BR112013010043A patent/BR112013010043A2/pt not_active IP Right Cessation
- 2011-10-27 US US13/881,613 patent/US20130217697A1/en not_active Abandoned
-
2016
- 2016-06-10 US US15/179,213 patent/US9789112B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012055944A1 (de) | 2012-05-03 |
| JP6049624B2 (ja) | 2016-12-21 |
| US9789112B2 (en) | 2017-10-17 |
| DE102010049708A1 (de) | 2012-05-03 |
| US20130217697A1 (en) | 2013-08-22 |
| US20160279134A1 (en) | 2016-09-29 |
| JP2013540795A (ja) | 2013-11-07 |
| EP2632429A1 (de) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013010043A2 (pt) | formulação farmacêutica na forma de filme e uso de uma combinação de excipientes farmacêuticas aceitáveis. | |
| BR112012013148A2 (pt) | formulação farmacêutica e uso | |
| DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
| HK1205690A1 (en) | Pharmaceutical composition and administration thereof | |
| CO6900149A2 (es) | Una composición farmacéutica que comprende los fitocanabinoides canabidivarina (cbdv) y canabidiol (cbd) | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| CO6801774A2 (es) | Compuestos de benzotiazol y su uso farmacéutico | |
| DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
| DK3278792T3 (da) | Lægemiddelformulering med forsinket udløsning | |
| BRPI0913822A2 (pt) | forma farmacêutica oral e uso da forma farmacêutica | |
| DK3222272T3 (da) | Farmaceutisk sammensætning med carbetocin | |
| DK2525798T3 (da) | Anæstetisk formulering | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| PL2842945T3 (pl) | Pochodna sulfonamidowa i jej zastosowanie medyczne | |
| BR112013014644A2 (pt) | composição farmacêutica e complexo | |
| IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| DK2652652T3 (da) | Medikmentadministration | |
| CO6890098A2 (es) | Compuesto pirazol y su uso farmaceutico | |
| CO6940408A2 (es) | Composiciones en forma de comprimido de disolución rápida para administración vaginal | |
| BR112014020992A2 (pt) | Composto,uso de composto na fabricação de um medicamento e composição farmacêutica | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| BR112013014189A8 (pt) | composição farmacêutica, uso de um agente de potencialização e uso de uma composição | |
| BRPI1014295A2 (pt) | composição e seu uso, filme co-estrusado e artigo | |
| BR112013000356A2 (pt) | formulação farmacêutica injetável de malfalano | |
| BR112012019473A2 (pt) | compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |